text.skipToContent text.skipToNavigation
You searched for "vivo"
Too many choices? Use the filter option on the left to narrow your product listing.
161-170 of 337 results
  • P5 Primary Cell 4D-Nucleofector<sup class=reg>®</sup> X Kit S
    Compare
    P5 Primary Cell 4D-Nucleofector® X Kit S
    Catalog #: V4XP-5032

    For efficient transfection of specific primary cells, e.g. HUVEC, in the 4D-Nucleofector® X Unit (20 µL format).

    Sales unit: kit
    SA
  • P2 Primary Cell 4D-Nucleofector<sup class=reg>®</sup> X Kit S
    Compare
    P2 Primary Cell 4D-Nucleofector® X Kit S
    Catalog #: V4XP-2032

    For efficient transfection of specific primary cells, e.g. mouse macrophages and NHDF, in the 4D-Nucleofector® X Unit (20 µL format).

    Sales unit: kit
    SA
  • P1 Primary Cell 96-well Nucleofector<sup class=reg>®</sup> Kit (960 RCT)
    Compare
    P1 Primary Cell 96-well Nucleofector® Kit (960 RCT)
    Catalog #: V4SP-1960
    For medium-throughput transfection of primary cells, e.g. human ADSc or MSC, when working with the 4D-Nucleofector® 96-well Unit.
    Sales unit: kit
    SA
  • P1 Primary Cell 384-well Nucleofector<sup class=reg>®</sup> Kit
    Compare
    P1 Primary Cell 384-well Nucleofector® Kit
    Catalog #: V5SP-1002

    For high-throughput transfection of primary cells, e.g. human ADSC or MSC, when working with the 384-well HT Nucleofector® System.

    Sales unit: kit
    SA
  • Eppendorf® 20–300 µL Biopur™ Pipette Tips
    Compare
    Eppendorf® 20–300 µL Biopur™ Pipette Tips
    Catalog #: 25-416

    Eppendorf® Biopur Tips, 20-300 µL, 5x96 tips/tray. Ideal for use in the endotoxin test with a multi-channel pipettor.

    Sales unit: each
    EA
  • Service Contract Type A /Bio-Tek ELx808
    Compare
    Sales unit: each
    EA
  • Service Contract Type B /Bio-Tek ELx808
    Compare
    Sales unit: each
    EA
  • LAL Reagent Reservoirs
    Compare
    LAL Reagent Reservoirs
    Catalog #: 00190035

    LAL Reagent Reservoirs used with multi-channel pipettors ideal for endotoxin testing. 10/pack.  

    Sales unit: each
    EA
  • ProCHO™ 4 Protein-free CHO Medium - part code discontinued use BEBP12-029Q
    Compare
    ProCHO™ 4 Protein-free CHO Medium - part code discontinued use BEBP12-029Q
    Catalog #: 12-029Q
    ProCHOTM 4, Protein free CHO Medium, with 0.1% Pluronic® F-68 and phenol red, without L-Glutamin, hypoxanthine or thymidine, 1 L.

     

    This product is discontinued.

    Sales unit: Bottle
    BOT
  • IMDM with L-Glutamine and HEPES
    Compare
    IMDM with L-Glutamine and HEPES
    Catalog #: 12-722F
    IMDM with L-Glutamine and 25 mM HEPES, 500 mL
    Sales unit: each
    EA
1-10 of 210 results
  • References - X-Vivo™
    Overview of relevant references
  • Primary Normal Human Cells and Media
    In Vivo Relevance. In Vitro Results. Updated and revised cell content.
  • X-VIVO Reference Guide 2025
    A curated list of peer-reviewed articles related to X-VIVO RUO media as used for culturing different primary cells and is a resource for potential consumers to find scientific data.
  • Building Better In Vitro Models Using the Quasi Vivo® System
    Overview webinar providing details and application data using the Quasi Vivo® Systems delivered by Dr. Kelly Davidge, Scientist at Kirkstall Inc.
    Watch Video
  • Terms and Conditions TheraPEAK® T-VIVO® Sample Request Program
    Terms and Conditions TheraPEAK® T-VIVO® Sample Requests
  • Instructions for Use – TheraPEAK® X-VIVO® Cell Culture Medium
    Instructions for how to use the X-VIVO® Media Series
  • TheraPEAK® T-VIVO® Cell Culture Medium – Overview
    View or download this document for a comprehensive overview and learn how the chemically defined TheraPEAK® T-VIVO® Medium enhances T-cell culture and accelerates therapy development.
  • TheraPEAK® X-VIVO® Hematopoietic Cell Culture Medium
    Serum-free, GMP produced medium for cell therapy applications
  • Non-viral Gene Modification for Ex-vivo Cell Therapy
    In this interview our Director Transfection R&D discusses the advantages of non-viral transfection technologies for CRISPR- or transposon-based genetic modification cell and gene therapy.
  • A Novel In Vitro Liver Cell Culture Flow System Allowing Long-Term Metabolism and Hepatotoxicity Studies]
    Manuscript published in Applied In Vitro Toxicology journal describes improvement of CYP450 phenotype of primary cryopreserved hepatocytes using Quasi Vivo® System